**Question:** All of the following drugs acts as potassium sparing diuretics, EXCEPT:

A. Spironolactone
B. Amiloride
C. Triamterene
D. Furosemide

**Core Concept:** Potassium-sparing diuretics are medications that do not significantly increase urinary potassium excretion, thereby preventing hypokalemia (low potassium levels) that can occur with other types of diuretics like loop diuretics (e.g., furosemide).

**Why the Correct Answer is Right:** Furosemide (D) is a loop diuretic, which primarily targets the ascending limb of the loop of Henle in the nephron, leading to increased urinary potassium excretion. As a result, furosemide is not considered a potassium-sparing diuretic.

**Why Each Wrong Option is Incorrect:**

A. Spironolactone (A) is a potassium-sparing diuretic, acting as an aldosterone antagonist. It blocks the effects of aldosterone, thereby reducing sodium and water reabsorption in the distal convoluted tubule and collecting duct, leading to natriuresis (sodium excretion) and kaliuresis (potassium excretion).

B. Amiloride (B) is primarily a sodium channel blocker, inhibiting the sodium-hydrogen exchange in the distal convoluted tubule and collecting duct, leading to reduced sodium reabsorption and increased sodium excretion (natriuresis). However, it does not directly affect potassium excretion, making it a potassium-sparing diuretic.

C. Triamterene (C) is also a potassium-sparing diuretic, functioning as an aldosterone antagonist. It competitively inhibits the reabsorption of sodium and water while promoting potassium excretion.

**Clinical Pearl:** In clinical practice, potassium-sparing diuretics are often used to manage high blood pressure, edema, and congestive heart failure, particularly in patients with hypokalemia (low potassium levels) as they prevent the loss of potassium in the urine.